PS-341
Term · Oncology and biomedicine · MLC-T-ONC-007033
A drug used to treat adults with multiple myeloma or mantle cell lymphoma. It is also being studied in the treatment of other types of cancer. PS-341 blocks the action of enzymes called proteasomes, which may help keep cancer cells from growing and may kill them. It is a type of proteasome inhibitor. Also called bortezomib and Velcade.
| Identifier | MLC-T-ONC-007033 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | bortezomib; Velcade |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-007033",
"term": "PS-341",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat adults with multiple myeloma or mantle cell lymphoma. It is also being studied in the treatment of other types of cancer. PS-341 blocks the action of enzymes called proteasomes, which may help keep cancer cells from growing and may kill them. It is a type of proteasome inhibitor. Also called bortezomib and Velcade.",
"expansions": [
"bortezomib",
"Velcade"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/ps-341/"
}
Record 13,791 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.